The Prize will constist of a diploma, a free registration and a 500€ travel grant to attend the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2020) and EFMC Young Medicinal Chemist Symposium (EFMC-YMCS 2020) which will take place in Basel, Switzerland on September 6-10 & 10-11, 2020.
Who can apply?
- European PhD students (or up to one year after PhD)
- Abstract of the poster to be presented at the EFMC-ISMC 2020 & EFMC-YMCS 2020
- List of publications
- Cover letter: « Why is my research worth the Prize »
How to apply?
- Via the online form
Deadline for submission: January 31, 2020
To acknowledge outstanding achievements in the field of Medicinal Chemistry, EFMC confers every two years three Awards.
All 3 awards consist of a diploma, € 7.500 and an invitation to give a headline presentation at EFMC-ISMC 2020.
Deadline: January 31, 2020
The 2020 Awards will be presented at the XXVI EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC'20) to be held in Basel, Switzerland on September 6-10, 2020.
Nominations for these Awards consist of a nomination letter, a brief CV including a list of selected publications and two supporting letters. Self-nominations are also accepted. The nominations should be submitted to Dr Yves Auberson, President of the EFMC, via the following link.
To acknowledge and recognise outstanding young medicinal chemists (≤ 12 years after PhD) working in European industry and academia.
The two Prizes consists of a diploma, € 1.000 and an invitation for a short presentation at an EFMC symposium.
Deadline: January 31, 2020
The 2020 Prizes will be presented at the XXVI EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC'20) to be held in Basel, Switzerland on September 6-10, 2020.
Applications and regulations can be found on https://www.efmc.info/efmc-prizes
We are in the process of compiling and writing a history of EFMC, more of which in the coming months. As part of this, we are collecting pictures that illustrate the first 50 years. If you have photos from EFMC events or EFMC activities, please share them with us. They will add tremendously to the written narrative. We would be very grateful.
Events and EFMC-related activities we would be delighted to hear from you. Please get in touch with us at email@example.com.
The 2020 IUPAC-Richter Prize will be presented during the XXVI. EFMC International Symposium on Medicinal Chemistry (September 6-10, 2020) in Basel (Switzerland), where the recipient will also give a plenary lecture on the subject of his/her research.
The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.
Prize USD 10 000
The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health.
Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional autobiography of not more than two pages, and a one-page summary of what the individual considers to be his/her activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.
For further information please contact Prof. Janos Fischer, Chairman of the IUPAC Sub-committee on Drug Discovery and Development, by email at firstname.lastname@example.org
Nomination materials should be uploaded by 15 December 2019 to IUPAC Secretariat via the following form
The 2019 Prizes have been conferred during EFMC-ASMC’19 in Athens, Greece.
The « EFMC Prize for a Young Medicinal Chemist in Academia » and the « EFMC Prize for a Young medicinal chemist in Industry » have been established by the EFMC to acknowledge and recognize an outstanding young medicinal chemist working in academia or in industry within Europe. The prizes are given annually and consist of a diploma, 1.000€ and an invitation for a short presentation at an EFMC Symposium. Two runners-up are also identified and acknowledged.
Winner of the Industry Prize was Radka Snajdrova (Novartis Pharma, Switzerland) and she gave a talk on the “Cipargamin-Biocatalysis in the Discovery and Development of an Antimalarial Drug”. The most meritorious runners-up were Jo Alen (Grünenthal, Germany) & Jacob Bush (GSK, United Kingdom).
Andreas Koeberle (Friedrich-Schiller-University Jena, Germany) won the 2019 EFMC Prize for a Young Medicinal Chemist in Academia. At the EFMC-ASMC’19 Symposium, he gave a talk entitled “From the Elucidation of the Mechanism of Vitamin E to the Design of Innovative Drugs that Limit Inflammation and Enhance Resolution“. Anna Katharina Hirsch (HIPS, Germany) & Kamil Musilek (University of Hradec Kralove, Czech Republic) have been identified and acknowledged as runners-up.
Photographer - Fabien Venturi
Here is the list of 5 laureates:
- Fabian Hulpia (University of Ghent, Belgium)
- Femke Meijer (Eindhoven University of Technology, The Netherlands)
- Vasiliki Pardali (National and Kapodistrian University of Athens, Greece)
- Naoya Shindo (Kyushu University, Japan)
- Rhia Stone (University of Queensland, Australia)
The EFMC Best Poster Prizes consist of a diploma and a 200€ cash-prize – and are awarded at every EFMC Event.
Photographer - Fabien Venturi
For many years the lack of a visibility of medicinal chemistry as a scientific discipline within the panel structure of the European Research Council (ERC) was a limiting factor for medicinal chemists to submit grant applications and to be successful.
The European Federation for Medicinal Chemistry (EFMC) invited Prof. Klaus Bock, at that time Vice-President of ERC, to present a lecture at the opening ceremony of its flagship event, the International Symposium on Medicinal Chemistry (EFMC-ISMC) in Manchester, August 2016. During a follow-up meeting with him, the EFMC President and President-elect discussed this matter and showed the important position of medicinal chemistry in the scientific landscape.
We are grateful that medicinal chemistry is now listed for the first time as a keyword (PE5_18) in the Synthetic Chemistry and Materials Panel (PE5) of the Physical Sciences and Engineering field. This is adopted for all 2019 calls for Starting, Consolidator and Advanced Grants within ERC.
We hope that this will largely increase the visibility of medicinal chemistry within ERC, that rapidly became the most prestigious funding body to support excellent, investigator-driven frontier research in Europe.
We wish all scientists a lot of success in submitting their grant applications in one of the ERC calls.
Workshop at the European Parliament: EFMC as the voice of medicinal chemistry in Europe. (Editorial by Yves P. Auberson, EFMC President)
EFMC represents a research community that plays an important role in society. By providing tools to better understand the biology of human diseases and developing new drugs, chemical biologists and medicinal chemists can address issues that represent a huge burden to patients, families and social welfare. In particular, there is an enormous need for improved treatments of neurodegenerative diseases, such as Parkinson’s disease.
<p >Our recent workshop in Brussels “Parkinson’s disease: understanding the causes to find a cure” was co-organized with EuChemS, alongside Members of the European Parliament, and representatives from the European Commission and the European Food Safety Agency (EFSA). The workshop aimed to increase awareness of both patients and researchers needs, as well as review the latest understanding of the causes of the disease. Further information on this event is available in the press release, and all presentations can be viewed at https://www.euchems.eu/parkinsons-disease-causes-and-cures-workshop/
By participating in such activities, EFMC both supports the cause of patients and helps increase awareness of the need for research funding, and for policies facilitating the task of our scientific community to address these complex issues. Please take advantage of this event to share our efforts within our network, and let people know that EFMC really cares.